Shopping Cart 0
Cart Subtotal
USD 0

Global Nanomedicine Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3480

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5220

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 6960
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.

Scope of the Report:

This report studies the Nanomedicine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nanomedicine market by product type and applications/end industries.

As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.

Potential pipeline of products based on the nanomolecules and associated technologies are anticipated to drive market with potential avenues of growth. Presence of around 40% of products in phase II of clinical development, is anticipated to result in a number of key commercialization over the coming decade influencing revenue generation over the forecast period. The customized treatment options available for eradication of genetic abnormalities also makes this technology a substantial option for precision medicine.

Asia Pacific is expected to witness lucrative growth through to 2025 as a result of rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, rise in the number of venture capital investors from developing economies of this region and increasing international research collaborations are anticipated to propel growth in nanotechnology-based healthcare industry.

The global Nanomedicine market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nanomedicine.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Combimatrix

Ablynx

Abraxis Bioscience

Celgene

Mallinckrodt

Arrowhead Research

GE Healthcare

Merck

Pfizer

Nanosphere

Epeius Biotechnologies

Cytimmune Sciences

Nanospectra Biosciences

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Quantum dots

Nanoparticles

Nanoshells

Nanotubes

Nanodevices

Market Segment by Applications, can be divided into

Segmentation encompasses oncology

Infectious diseases

Cardiology

Orthopedics

Others

READ MORE

Table Of Content

Scope

Table of Contents

1 Nanomedicine Market Overview

1.1 Product Overview and Scope of Nanomedicine

1.2 Classification of Nanomedicine by Types

1.2.1 Global Nanomedicine Revenue Comparison by Types (2017-2023)

1.2.2 Global Nanomedicine Revenue Market Share by Types in 2017

1.2.3 Quantum dots

1.2.4 Nanoparticles

1.2.5 Nanoshells

1.2.6 Nanotubes

1.2.7 Nanodevices

1.3 Global Nanomedicine Market by Application

1.3.1 Global Nanomedicine Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Segmentation encompasses oncology

1.3.3 Infectious diseases

1.3.4 Cardiology

1.3.5 Orthopedics

1.3.6 Others

1.4 Global Nanomedicine Market by Regions

1.4.1 Global Nanomedicine Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Nanomedicine Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Nanomedicine Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nanomedicine Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Nanomedicine Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nanomedicine Status and Prospect (2013-2023)

1.5 Global Market Size of Nanomedicine (2013-2023)

2 Manufacturers Profiles

2.1 Combimatrix

2.1.1 Business Overview

2.1.2 Nanomedicine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Combimatrix Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.2 Ablynx

2.2.1 Business Overview

2.2.2 Nanomedicine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Ablynx Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.3 Abraxis Bioscience

2.3.1 Business Overview

2.3.2 Nanomedicine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Abraxis Bioscience Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.4 Celgene

2.4.1 Business Overview

2.4.2 Nanomedicine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Celgene Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.5 Mallinckrodt

2.5.1 Business Overview

2.5.2 Nanomedicine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Mallinckrodt Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.6 Arrowhead Research

2.6.1 Business Overview

2.6.2 Nanomedicine Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Arrowhead Research Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.7 GE Healthcare

2.7.1 Business Overview

2.7.2 Nanomedicine Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 GE Healthcare Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.8 Merck

2.8.1 Business Overview

2.8.2 Nanomedicine Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Merck Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.9 Pfizer

2.9.1 Business Overview

2.9.2 Nanomedicine Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Pfizer Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.10 Nanosphere

2.10.1 Business Overview

2.10.2 Nanomedicine Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Nanosphere Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.11 Epeius Biotechnologies

2.11.1 Business Overview

2.11.2 Nanomedicine Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Epeius Biotechnologies Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.12 Cytimmune Sciences

2.12.1 Business Overview

2.12.2 Nanomedicine Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Cytimmune Sciences Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.13 Nanospectra Biosciences

2.13.1 Business Overview

2.13.2 Nanomedicine Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Nanospectra Biosciences Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

3 Global Nanomedicine Market Competition, by Players

3.1 Global Nanomedicine Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Nanomedicine Players Market Share

3.2.2 Top 10 Nanomedicine Players Market Share

3.3 Market Competition Trend

4 Global Nanomedicine Market Size by Regions

4.1 Global Nanomedicine Revenue and Market Share by Regions

4.2 North America Nanomedicine Revenue and Growth Rate (2013-2018)

4.3 Europe Nanomedicine Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Nanomedicine Revenue and Growth Rate (2013-2018)

4.5 South America Nanomedicine Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Nanomedicine Revenue and Growth Rate (2013-2018)

5 North America Nanomedicine Revenue by Countries

5.1 North America Nanomedicine Revenue by Countries (2013-2018)

5.2 USA Nanomedicine Revenue and Growth Rate (2013-2018)

5.3 Canada Nanomedicine Revenue and Growth Rate (2013-2018)

5.4 Mexico Nanomedicine Revenue and Growth Rate (2013-2018)

6 Europe Nanomedicine Revenue by Countries

6.1 Europe Nanomedicine Revenue by Countries (2013-2018)

6.2 Germany Nanomedicine Revenue and Growth Rate (2013-2018)

6.3 UK Nanomedicine Revenue and Growth Rate (2013-2018)

6.4 France Nanomedicine Revenue and Growth Rate (2013-2018)

6.5 Russia Nanomedicine Revenue and Growth Rate (2013-2018)

6.6 Italy Nanomedicine Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Nanomedicine Revenue by Countries

7.1 Asia-Pacific Nanomedicine Revenue by Countries (2013-2018)

7.2 China Nanomedicine Revenue and Growth Rate (2013-2018)

7.3 Japan Nanomedicine Revenue and Growth Rate (2013-2018)

7.4 Korea Nanomedicine Revenue and Growth Rate (2013-2018)

7.5 India Nanomedicine Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Nanomedicine Revenue and Growth Rate (2013-2018)

8 South America Nanomedicine Revenue by Countries

8.1 South America Nanomedicine Revenue by Countries (2013-2018)

8.2 Brazil Nanomedicine Revenue and Growth Rate (2013-2018)

8.3 Argentina Nanomedicine Revenue and Growth Rate (2013-2018)

8.4 Colombia Nanomedicine Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Nanomedicine by Countries

9.1 Middle East and Africa Nanomedicine Revenue by Countries (2013-2018)

9.2 Saudi Arabia Nanomedicine Revenue and Growth Rate (2013-2018)

9.3 UAE Nanomedicine Revenue and Growth Rate (2013-2018)

9.4 Egypt Nanomedicine Revenue and Growth Rate (2013-2018)

9.5 Nigeria Nanomedicine Revenue and Growth Rate (2013-2018)

9.6 South Africa Nanomedicine Revenue and Growth Rate (2013-2018)

10 Global Nanomedicine Market Segment by Type

10.1 Global Nanomedicine Revenue and Market Share by Type (2013-2018)

10.2 Global Nanomedicine Market Forecast by Type (2018-2023)

10.3 Quantum dots Revenue Growth Rate (2013-2023)

10.4 Nanoparticles Revenue Growth Rate (2013-2023)

10.5 Nanoshells Revenue Growth Rate (2013-2023)

10.6 Nanotubes Revenue Growth Rate (2013-2023)

10.7 Nanodevices Revenue Growth Rate (2013-2023)

11 Global Nanomedicine Market Segment by Application

11.1 Global Nanomedicine Revenue Market Share by Application (2013-2018)

11.2 Nanomedicine Market Forecast by Application (2018-2023)

11.3 Segmentation encompasses oncology Revenue Growth (2013-2018)

11.4 Infectious diseases Revenue Growth (2013-2018)

11.5 Cardiology Revenue Growth (2013-2018)

11.6 Orthopedics Revenue Growth (2013-2018)

11.7 Others Revenue Growth (2013-2018)

12 Global Nanomedicine Market Size Forecast (2018-2023)

12.1 Global Nanomedicine Market Size Forecast (2018-2023)

12.2 Global Nanomedicine Market Forecast by Regions (2018-2023)

12.3 North America Nanomedicine Revenue Market Forecast (2018-2023)

12.4 Europe Nanomedicine Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Nanomedicine Revenue Market Forecast (2018-2023)

12.6 South America Nanomedicine Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Nanomedicine Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Nanomedicine Picture

Table Product Specifications of Nanomedicine

Table Global Nanomedicine and Revenue (Million USD) Market Split by Product Type

Figure Global Nanomedicine Revenue Market Share by Types in 2017

Figure Quantum dots Picture

Figure Nanoparticles Picture

Figure Nanoshells Picture

Figure Nanotubes Picture

Figure Nanodevices Picture

Table Global Nanomedicine Revenue (Million USD) by Application (2013-2023)

Figure Nanomedicine Revenue Market Share by Applications in 2017

Figure Segmentation encompasses oncology Picture

Figure Infectious diseases Picture

Figure Cardiology Picture

Figure Orthopedics Picture

Figure Others Picture

Table Global Market Nanomedicine Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Nanomedicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Nanomedicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Nanomedicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Nanomedicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Nanomedicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Nanomedicine Revenue (Million USD) and Growth Rate (2013-2023)

Table Combimatrix Basic Information, Manufacturing Base and Competitors

Table Combimatrix Nanomedicine Type and Applications

Table Combimatrix Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Ablynx Basic Information, Manufacturing Base and Competitors

Table Ablynx Nanomedicine Type and Applications

Table Ablynx Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Abraxis Bioscience Basic Information, Manufacturing Base and Competitors

Table Abraxis Bioscience Nanomedicine Type and Applications

Table Abraxis Bioscience Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Celgene Basic Information, Manufacturing Base and Competitors

Table Celgene Nanomedicine Type and Applications

Table Celgene Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Mallinckrodt Basic Information, Manufacturing Base and Competitors

Table Mallinckrodt Nanomedicine Type and Applications

Table Mallinckrodt Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Arrowhead Research Basic Information, Manufacturing Base and Competitors

Table Arrowhead Research Nanomedicine Type and Applications

Table Arrowhead Research Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table GE Healthcare Basic Information, Manufacturing Base and Competitors

Table GE Healthcare Nanomedicine Type and Applications

Table GE Healthcare Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Nanomedicine Type and Applications

Table Merck Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Nanomedicine Type and Applications

Table Pfizer Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Nanosphere Basic Information, Manufacturing Base and Competitors

Table Nanosphere Nanomedicine Type and Applications

Table Nanosphere Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Epeius Biotechnologies Basic Information, Manufacturing Base and Competitors

Table Epeius Biotechnologies Nanomedicine Type and Applications

Table Epeius Biotechnologies Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Cytimmune Sciences Basic Information, Manufacturing Base and Competitors

Table Cytimmune Sciences Nanomedicine Type and Applications

Table Cytimmune Sciences Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Nanospectra Biosciences Basic Information, Manufacturing Base and Competitors

Table Nanospectra Biosciences Nanomedicine Type and Applications

Table Nanospectra Biosciences Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Global Nanomedicine Revenue (Million USD) by Players (2013-2018)

Table Global Nanomedicine Revenue Share by Players (2013-2018)

Figure Global Nanomedicine Revenue Share by Players in 2016

Figure Global Nanomedicine Revenue Share by Players in 2017

Figure Global Top 5 Players Nanomedicine Revenue Market Share in 2017

Figure Global Top 10 Players Nanomedicine Revenue Market Share in 2017

Figure Global Nanomedicine Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Nanomedicine Revenue (Million USD) by Regions (2013-2018)

Table Global Nanomedicine Revenue Market Share by Regions (2013-2018)

Figure Global Nanomedicine Revenue Market Share by Regions (2013-2018)

Figure Global Nanomedicine Revenue Market Share by Regions in 2017

Figure North America Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Europe Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Nanomedicine Revenue and Growth Rate (2013-2018)

Figure South America Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Nanomedicine Revenue and Growth Rate (2013-2018)

Table North America Nanomedicine Revenue by Countries (2013-2018)

Table North America Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure North America Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure North America Nanomedicine Revenue Market Share by Countries in 2017

Figure USA Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Canada Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Mexico Nanomedicine Revenue and Growth Rate (2013-2018)

Table Europe Nanomedicine Revenue (Million USD) by Countries (2013-2018)

Figure Europe Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure Europe Nanomedicine Revenue Market Share by Countries in 2017

Figure Germany Nanomedicine Revenue and Growth Rate (2013-2018)

Figure UK Nanomedicine Revenue and Growth Rate (2013-2018)

Figure France Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Russia Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Italy Nanomedicine Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Nanomedicine Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Nanomedicine Revenue Market Share by Countries in 2017

Figure China Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Japan Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Korea Nanomedicine Revenue and Growth Rate (2013-2018)

Figure India Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Nanomedicine Revenue and Growth Rate (2013-2018)

Table South America Nanomedicine Revenue by Countries (2013-2018)

Table South America Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure South America Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure South America Nanomedicine Revenue Market Share by Countries in 2017

Figure Brazil Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Argentina Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Colombia Nanomedicine Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Nanomedicine Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Nanomedicine Revenue Market Share by Countries in 2017

Figure Saudi Arabia Nanomedicine Revenue and Growth Rate (2013-2018)

Figure UAE Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Egypt Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Nigeria Nanomedicine Revenue and Growth Rate (2013-2018)

Figure South Africa Nanomedicine Revenue and Growth Rate (2013-2018)

Table Global Nanomedicine Revenue (Million USD) by Type (2013-2018)

Table Global Nanomedicine Revenue Share by Type (2013-2018)

Figure Global Nanomedicine Revenue Share by Type (2013-2018)

Figure Global Nanomedicine Revenue Share by Type in 2017

Table Global Nanomedicine Revenue Forecast by Type (2018-2023)

Figure Global Nanomedicine Market Share Forecast by Type (2018-2023)

Figure Global Quantum dots Revenue Growth Rate (2013-2018)

Figure Global Nanoparticles Revenue Growth Rate (2013-2018)

Figure Global Nanoshells Revenue Growth Rate (2013-2018)

Figure Global Nanotubes Revenue Growth Rate (2013-2018)

Figure Global Nanodevices Revenue Growth Rate (2013-2018)

Table Global Nanomedicine Revenue by Application (2013-2018)

Table Global Nanomedicine Revenue Share by Application (2013-2018)

Figure Global Nanomedicine Revenue Share by Application (2013-2018)

Figure Global Nanomedicine Revenue Share by Application in 2017

Table Global Nanomedicine Revenue Forecast by Application (2018-2023)

Figure Global Nanomedicine Market Share Forecast by Application (2018-2023)

Figure Global Segmentation encompasses oncology Revenue Growth Rate (2013-2018)

Figure Global Infectious diseases Revenue Growth Rate (2013-2018)

Figure Global Cardiology Revenue Growth Rate (2013-2018)

Figure Global Orthopedics Revenue Growth Rate (2013-2018)

Figure Global Others Revenue Growth Rate (2013-2018)

Figure Global Nanomedicine Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Nanomedicine Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Nanomedicine Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Nanomedicine Revenue Market Forecast (2018-2023)

Figure Europe Nanomedicine Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Nanomedicine Revenue Market Forecast (2018-2023)

Figure South America Nanomedicine Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Nanomedicine Revenue Market Forecast (2018-2023)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Combimatrix

Ablynx

Abraxis Bioscience

Celgene

Mallinckrodt

Arrowhead Research

GE Healthcare

Merck

Pfizer

Nanosphere

Epeius Biotechnologies

Cytimmune Sciences

Nanospectra Biosciences

Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.

Scope of the Report:

This report studies the Nanomedicine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nanomedicine market by product type and applications/end industries.

As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.

Potential pipeline of products based on the nanomolecules and associated technologies are anticipated to drive market with potential avenues of growth. Presence of around 40% of products in phase II of clinical development, is anticipated to result in a number of key commercialization over the coming decade influencing revenue generation over the forecast period. The customized treatment options available for eradication of genetic abnormalities also makes this technology a substantial option for precision medicine.

Asia Pacific is expected to witness lucrative growth through to 2025 as a result of rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, rise in the number of venture capital investors from developing economies of this region and increasing international research collaborations are anticipated to propel growth in nanotechnology-based healthcare industry.

The global Nanomedicine market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nanomedicine.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Combimatrix

Ablynx

Abraxis Bioscience

Celgene

Mallinckrodt

Arrowhead Research

GE Healthcare

Merck

Pfizer

Nanosphere

Epeius Biotechnologies

Cytimmune Sciences

Nanospectra Biosciences

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Quantum dots

Nanoparticles

Nanoshells

Nanotubes

Nanodevices

Market Segment by Applications, can be divided into

Segmentation encompasses oncology

Infectious diseases

Cardiology

Orthopedics

Others

READ MORE

Scope

Table of Contents

1 Nanomedicine Market Overview

1.1 Product Overview and Scope of Nanomedicine

1.2 Classification of Nanomedicine by Types

1.2.1 Global Nanomedicine Revenue Comparison by Types (2017-2023)

1.2.2 Global Nanomedicine Revenue Market Share by Types in 2017

1.2.3 Quantum dots

1.2.4 Nanoparticles

1.2.5 Nanoshells

1.2.6 Nanotubes

1.2.7 Nanodevices

1.3 Global Nanomedicine Market by Application

1.3.1 Global Nanomedicine Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Segmentation encompasses oncology

1.3.3 Infectious diseases

1.3.4 Cardiology

1.3.5 Orthopedics

1.3.6 Others

1.4 Global Nanomedicine Market by Regions

1.4.1 Global Nanomedicine Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Nanomedicine Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Nanomedicine Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nanomedicine Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Nanomedicine Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nanomedicine Status and Prospect (2013-2023)

1.5 Global Market Size of Nanomedicine (2013-2023)

2 Manufacturers Profiles

2.1 Combimatrix

2.1.1 Business Overview

2.1.2 Nanomedicine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Combimatrix Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.2 Ablynx

2.2.1 Business Overview

2.2.2 Nanomedicine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Ablynx Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.3 Abraxis Bioscience

2.3.1 Business Overview

2.3.2 Nanomedicine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Abraxis Bioscience Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.4 Celgene

2.4.1 Business Overview

2.4.2 Nanomedicine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Celgene Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.5 Mallinckrodt

2.5.1 Business Overview

2.5.2 Nanomedicine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Mallinckrodt Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.6 Arrowhead Research

2.6.1 Business Overview

2.6.2 Nanomedicine Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Arrowhead Research Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.7 GE Healthcare

2.7.1 Business Overview

2.7.2 Nanomedicine Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 GE Healthcare Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.8 Merck

2.8.1 Business Overview

2.8.2 Nanomedicine Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Merck Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.9 Pfizer

2.9.1 Business Overview

2.9.2 Nanomedicine Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Pfizer Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.10 Nanosphere

2.10.1 Business Overview

2.10.2 Nanomedicine Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Nanosphere Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.11 Epeius Biotechnologies

2.11.1 Business Overview

2.11.2 Nanomedicine Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Epeius Biotechnologies Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.12 Cytimmune Sciences

2.12.1 Business Overview

2.12.2 Nanomedicine Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Cytimmune Sciences Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

2.13 Nanospectra Biosciences

2.13.1 Business Overview

2.13.2 Nanomedicine Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Nanospectra Biosciences Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

3 Global Nanomedicine Market Competition, by Players

3.1 Global Nanomedicine Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Nanomedicine Players Market Share

3.2.2 Top 10 Nanomedicine Players Market Share

3.3 Market Competition Trend

4 Global Nanomedicine Market Size by Regions

4.1 Global Nanomedicine Revenue and Market Share by Regions

4.2 North America Nanomedicine Revenue and Growth Rate (2013-2018)

4.3 Europe Nanomedicine Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Nanomedicine Revenue and Growth Rate (2013-2018)

4.5 South America Nanomedicine Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Nanomedicine Revenue and Growth Rate (2013-2018)

5 North America Nanomedicine Revenue by Countries

5.1 North America Nanomedicine Revenue by Countries (2013-2018)

5.2 USA Nanomedicine Revenue and Growth Rate (2013-2018)

5.3 Canada Nanomedicine Revenue and Growth Rate (2013-2018)

5.4 Mexico Nanomedicine Revenue and Growth Rate (2013-2018)

6 Europe Nanomedicine Revenue by Countries

6.1 Europe Nanomedicine Revenue by Countries (2013-2018)

6.2 Germany Nanomedicine Revenue and Growth Rate (2013-2018)

6.3 UK Nanomedicine Revenue and Growth Rate (2013-2018)

6.4 France Nanomedicine Revenue and Growth Rate (2013-2018)

6.5 Russia Nanomedicine Revenue and Growth Rate (2013-2018)

6.6 Italy Nanomedicine Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Nanomedicine Revenue by Countries

7.1 Asia-Pacific Nanomedicine Revenue by Countries (2013-2018)

7.2 China Nanomedicine Revenue and Growth Rate (2013-2018)

7.3 Japan Nanomedicine Revenue and Growth Rate (2013-2018)

7.4 Korea Nanomedicine Revenue and Growth Rate (2013-2018)

7.5 India Nanomedicine Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Nanomedicine Revenue and Growth Rate (2013-2018)

8 South America Nanomedicine Revenue by Countries

8.1 South America Nanomedicine Revenue by Countries (2013-2018)

8.2 Brazil Nanomedicine Revenue and Growth Rate (2013-2018)

8.3 Argentina Nanomedicine Revenue and Growth Rate (2013-2018)

8.4 Colombia Nanomedicine Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Nanomedicine by Countries

9.1 Middle East and Africa Nanomedicine Revenue by Countries (2013-2018)

9.2 Saudi Arabia Nanomedicine Revenue and Growth Rate (2013-2018)

9.3 UAE Nanomedicine Revenue and Growth Rate (2013-2018)

9.4 Egypt Nanomedicine Revenue and Growth Rate (2013-2018)

9.5 Nigeria Nanomedicine Revenue and Growth Rate (2013-2018)

9.6 South Africa Nanomedicine Revenue and Growth Rate (2013-2018)

10 Global Nanomedicine Market Segment by Type

10.1 Global Nanomedicine Revenue and Market Share by Type (2013-2018)

10.2 Global Nanomedicine Market Forecast by Type (2018-2023)

10.3 Quantum dots Revenue Growth Rate (2013-2023)

10.4 Nanoparticles Revenue Growth Rate (2013-2023)

10.5 Nanoshells Revenue Growth Rate (2013-2023)

10.6 Nanotubes Revenue Growth Rate (2013-2023)

10.7 Nanodevices Revenue Growth Rate (2013-2023)

11 Global Nanomedicine Market Segment by Application

11.1 Global Nanomedicine Revenue Market Share by Application (2013-2018)

11.2 Nanomedicine Market Forecast by Application (2018-2023)

11.3 Segmentation encompasses oncology Revenue Growth (2013-2018)

11.4 Infectious diseases Revenue Growth (2013-2018)

11.5 Cardiology Revenue Growth (2013-2018)

11.6 Orthopedics Revenue Growth (2013-2018)

11.7 Others Revenue Growth (2013-2018)

12 Global Nanomedicine Market Size Forecast (2018-2023)

12.1 Global Nanomedicine Market Size Forecast (2018-2023)

12.2 Global Nanomedicine Market Forecast by Regions (2018-2023)

12.3 North America Nanomedicine Revenue Market Forecast (2018-2023)

12.4 Europe Nanomedicine Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Nanomedicine Revenue Market Forecast (2018-2023)

12.6 South America Nanomedicine Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Nanomedicine Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Nanomedicine Picture

Table Product Specifications of Nanomedicine

Table Global Nanomedicine and Revenue (Million USD) Market Split by Product Type

Figure Global Nanomedicine Revenue Market Share by Types in 2017

Figure Quantum dots Picture

Figure Nanoparticles Picture

Figure Nanoshells Picture

Figure Nanotubes Picture

Figure Nanodevices Picture

Table Global Nanomedicine Revenue (Million USD) by Application (2013-2023)

Figure Nanomedicine Revenue Market Share by Applications in 2017

Figure Segmentation encompasses oncology Picture

Figure Infectious diseases Picture

Figure Cardiology Picture

Figure Orthopedics Picture

Figure Others Picture

Table Global Market Nanomedicine Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Nanomedicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Nanomedicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Nanomedicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Nanomedicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Nanomedicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Nanomedicine Revenue (Million USD) and Growth Rate (2013-2023)

Table Combimatrix Basic Information, Manufacturing Base and Competitors

Table Combimatrix Nanomedicine Type and Applications

Table Combimatrix Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Ablynx Basic Information, Manufacturing Base and Competitors

Table Ablynx Nanomedicine Type and Applications

Table Ablynx Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Abraxis Bioscience Basic Information, Manufacturing Base and Competitors

Table Abraxis Bioscience Nanomedicine Type and Applications

Table Abraxis Bioscience Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Celgene Basic Information, Manufacturing Base and Competitors

Table Celgene Nanomedicine Type and Applications

Table Celgene Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Mallinckrodt Basic Information, Manufacturing Base and Competitors

Table Mallinckrodt Nanomedicine Type and Applications

Table Mallinckrodt Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Arrowhead Research Basic Information, Manufacturing Base and Competitors

Table Arrowhead Research Nanomedicine Type and Applications

Table Arrowhead Research Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table GE Healthcare Basic Information, Manufacturing Base and Competitors

Table GE Healthcare Nanomedicine Type and Applications

Table GE Healthcare Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Nanomedicine Type and Applications

Table Merck Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Nanomedicine Type and Applications

Table Pfizer Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Nanosphere Basic Information, Manufacturing Base and Competitors

Table Nanosphere Nanomedicine Type and Applications

Table Nanosphere Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Epeius Biotechnologies Basic Information, Manufacturing Base and Competitors

Table Epeius Biotechnologies Nanomedicine Type and Applications

Table Epeius Biotechnologies Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Cytimmune Sciences Basic Information, Manufacturing Base and Competitors

Table Cytimmune Sciences Nanomedicine Type and Applications

Table Cytimmune Sciences Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Nanospectra Biosciences Basic Information, Manufacturing Base and Competitors

Table Nanospectra Biosciences Nanomedicine Type and Applications

Table Nanospectra Biosciences Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)

Table Global Nanomedicine Revenue (Million USD) by Players (2013-2018)

Table Global Nanomedicine Revenue Share by Players (2013-2018)

Figure Global Nanomedicine Revenue Share by Players in 2016

Figure Global Nanomedicine Revenue Share by Players in 2017

Figure Global Top 5 Players Nanomedicine Revenue Market Share in 2017

Figure Global Top 10 Players Nanomedicine Revenue Market Share in 2017

Figure Global Nanomedicine Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Nanomedicine Revenue (Million USD) by Regions (2013-2018)

Table Global Nanomedicine Revenue Market Share by Regions (2013-2018)

Figure Global Nanomedicine Revenue Market Share by Regions (2013-2018)

Figure Global Nanomedicine Revenue Market Share by Regions in 2017

Figure North America Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Europe Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Nanomedicine Revenue and Growth Rate (2013-2018)

Figure South America Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Nanomedicine Revenue and Growth Rate (2013-2018)

Table North America Nanomedicine Revenue by Countries (2013-2018)

Table North America Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure North America Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure North America Nanomedicine Revenue Market Share by Countries in 2017

Figure USA Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Canada Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Mexico Nanomedicine Revenue and Growth Rate (2013-2018)

Table Europe Nanomedicine Revenue (Million USD) by Countries (2013-2018)

Figure Europe Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure Europe Nanomedicine Revenue Market Share by Countries in 2017

Figure Germany Nanomedicine Revenue and Growth Rate (2013-2018)

Figure UK Nanomedicine Revenue and Growth Rate (2013-2018)

Figure France Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Russia Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Italy Nanomedicine Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Nanomedicine Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Nanomedicine Revenue Market Share by Countries in 2017

Figure China Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Japan Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Korea Nanomedicine Revenue and Growth Rate (2013-2018)

Figure India Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Nanomedicine Revenue and Growth Rate (2013-2018)

Table South America Nanomedicine Revenue by Countries (2013-2018)

Table South America Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure South America Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure South America Nanomedicine Revenue Market Share by Countries in 2017

Figure Brazil Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Argentina Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Colombia Nanomedicine Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Nanomedicine Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Nanomedicine Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Nanomedicine Revenue Market Share by Countries in 2017

Figure Saudi Arabia Nanomedicine Revenue and Growth Rate (2013-2018)

Figure UAE Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Egypt Nanomedicine Revenue and Growth Rate (2013-2018)

Figure Nigeria Nanomedicine Revenue and Growth Rate (2013-2018)

Figure South Africa Nanomedicine Revenue and Growth Rate (2013-2018)

Table Global Nanomedicine Revenue (Million USD) by Type (2013-2018)

Table Global Nanomedicine Revenue Share by Type (2013-2018)

Figure Global Nanomedicine Revenue Share by Type (2013-2018)

Figure Global Nanomedicine Revenue Share by Type in 2017

Table Global Nanomedicine Revenue Forecast by Type (2018-2023)

Figure Global Nanomedicine Market Share Forecast by Type (2018-2023)

Figure Global Quantum dots Revenue Growth Rate (2013-2018)

Figure Global Nanoparticles Revenue Growth Rate (2013-2018)

Figure Global Nanoshells Revenue Growth Rate (2013-2018)

Figure Global Nanotubes Revenue Growth Rate (2013-2018)

Figure Global Nanodevices Revenue Growth Rate (2013-2018)

Table Global Nanomedicine Revenue by Application (2013-2018)

Table Global Nanomedicine Revenue Share by Application (2013-2018)

Figure Global Nanomedicine Revenue Share by Application (2013-2018)

Figure Global Nanomedicine Revenue Share by Application in 2017

Table Global Nanomedicine Revenue Forecast by Application (2018-2023)

Figure Global Nanomedicine Market Share Forecast by Application (2018-2023)

Figure Global Segmentation encompasses oncology Revenue Growth Rate (2013-2018)

Figure Global Infectious diseases Revenue Growth Rate (2013-2018)

Figure Global Cardiology Revenue Growth Rate (2013-2018)

Figure Global Orthopedics Revenue Growth Rate (2013-2018)

Figure Global Others Revenue Growth Rate (2013-2018)

Figure Global Nanomedicine Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Nanomedicine Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Nanomedicine Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Nanomedicine Revenue Market Forecast (2018-2023)

Figure Europe Nanomedicine Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Nanomedicine Revenue Market Forecast (2018-2023)

Figure South America Nanomedicine Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Nanomedicine Revenue Market Forecast (2018-2023)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Combimatrix

Ablynx

Abraxis Bioscience

Celgene

Mallinckrodt

Arrowhead Research

GE Healthcare

Merck

Pfizer

Nanosphere

Epeius Biotechnologies

Cytimmune Sciences

Nanospectra Biosciences